Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy

Oral Oncology

Volumn 34, Issue 2, 1998, Pages 105-111

  Ueta, E ^a   Osaki, T ^a   Yamamoto, T ^a   Yoneda, K ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Adenoid cystic carcinoma; Adoptive immunotherapy; Bone morphogenetic protein; Differentiation; Proliferating cell nuclear antigen

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARBOHYDRATE ANTIGEN; CYCLINE; FLUOROURACIL; GAMMA INTERFERON; PEPLEOMYCIN; RECOMBINANT INTERLEUKIN 2;

ADENOID CYSTIC CARCINOMA; ADOPTIVE IMMUNOTHERAPY; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COBALT THERAPY; FEMALE; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOID CYSTIC; CELL DIFFERENTIATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MAXILLARY NEOPLASMS; RADIOISOTOPE TELETHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032033098     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00063-8     Document Type: Article

References (38)

1. Hozumi M, Takenaga K, Tomida M, Okabe J. Role of leukocytes in ascites in the production of factor(s) stimulating differentiation of mouse myeloid leukemia cells. Gan 1977;68:643-652.
2. Hozumi M, Tomida M, Yamamoto-Yamaguchi Y, et al. Protein factors that regulate the growth and differentiation of mouse myeloid leukemia cells. Ciba Foundation Symposium 1990; 148:25-33.
3. Takase M, Yoshida H, Sato M. Induction of cells with phenotypic features of smooth muscle cells by treatment with DNA topoisomerase II inhibitor, etoposide, in a neoplastic human salivary intercalated duct cell line. Biomedicine and Pharmacotherapy 1992;46:333.
4. Hayashi Y, Yanagawa T, Azuma M, Yura Y, Yoshida H, Sato M. Induction of cells with a myoepithelial cell phenotype by treatment with dibutyryl cAMP-in human salivary adenocarcinoma cells grown in athymic nude mice. Virchows Archiv [Cell Pathology] 1985;50:1-11.
5. Kasai Y, Yoshida H, Sato M. Effects of 5-fluoro-2'-deoxyuridine5'-monophosphate on morphological features and biological markers of a neoplastic human salivary intercalated duct cell line grown in culture and as xenograft in nude mouse. Biomedicine and Pharmacotherapy 1992;46:310.
6. Sato M, Azuma M, Hayashi Y, Yoshida H, Yanagawa T, Yura Y. 5-Azacytidine induction of stable myoepithelial and acinar cells from a human salivary intercalated duct cell clone. Cancer Research 1987;47:4453t459.
7. 3 in a human salivary acinar cell line. Cancer Research 1989;49:5435-5442.
8. Azuma M, Kawamata H, Kasai Y, et al. Effects of retinoic acid on morphologic features and biologic markers of a neoplastic human salivary intercalated duct cell line in culture. Cancer Research 1988;48:7219-7225.
9. Guchelaar HJ, Timmer-Bosscha H, Dam-Meiring A, et al. Enhancement of cisplatin and etoposide cytotoxicity after alltrans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line. International Journal of Cancer 1993;55:442-447.
10. Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposmal all-trans-retinoic acid. Cancer Research 1993;53:2100-2104.
11. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clone in a human colonie cancer cell line in culture after treatment with sodium butyrate. Cancer Research 1984;44:3961-3969.
12. Azuma M, Hayashi Y, Yoshida H, et al. Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate. Cancer Research 1986;46:770-777.
13. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[α] pyrene. Proceedings of the National Academy of Sciences USA 1985;82:2394-2398.
14. Dogos L. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia. Cancer Treatment Research 1993;64:1-13.
15. Han G, Chang G, Connor MJ, Sidell N. Enhanced potency of 9cis versus all-trans-rctinoic acid to induce the differentiation of human neuroblastoma cells. Differentiation 1995;59:61-69.
16. Ohno R. Differentiation therapy of myelodysplastic syndromes with retinoic acid. Leukemia &Lymphoma 1994; 14:401-409.
17. Bour ES, Ward LK, Lornman GA, Isom HC. Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture. American Journal of Pathology 1996; 148:485-495.
18. Yang KD, Chuen HL, Shaio MF. Pentoxifylline augments but does not antagonize TNF alpha-mediated neuroblastoma cell differentiation: modulation of calcium mobilization but not cAMP. Biochemical and Biophysical Research Communications 1995;211:1006-1014.
19. Munoz-Fernandez MA, Cano E, O'Donnell CA, Doyle J, Liew FY, Fresno M. Tumor necrosis factor-alpha (TNF-alpha), interferon-gamma, and interleukin-6 but not TNF-beta induce differentiation of neuroblastoma cells: the role of nitric oxide. Journal of Neurochemistry 1994;62:1330-1336.
20. Berry DE, Lu Y, Schmidt B, et al. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene 1996; 12:18091819.
21. Young JD, Liu CC, Persechini PM, Cohn ZA. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunology Reviews 1988;103:161-202.
22. Golstein P. Cytolytic T-cell melodrama [news]. Nature 1987;7:12.
23. Russell JH, Dobos CB. Mechanisms of immune lysis. II. CTLinduced nuclear disintegration of the target begins within minutes of cell contact. Journal of Immunology 1980; 125:1256-1261.
24. Russell JH. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunology Reviews 1983;72:97118.
25. Stacey NH, Bishop CJ, Halliday JW, et al. Apoptosis as the model of cell death in antibody-dependent lymph ocytotoxicity. Journal of Cell Science 1985;74:169-179.
26. Allbritton NL, Verret CR, Wolley RC, Eisen HN. Calcium ion concentration and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes. Journal of Experimental Medicine 1988;167:514-527.
27. Martz E, Howell DM. CTL: virus control cells first and cytolytic cell second? DNA fragmentatin, apoptosis and the prelytic halt hypothesis. Immunology Today 1989; 10:79-86.
28. Sato M, Yoshida H, Kaji R, et al. Induction of bone formation in an adenoid cystic carcinoma of the maxillary sinus by adoptive immunotherapy involving intraarterial injection of lymphokineactivated killer cells and recombinant interleukin-2 in combination with radiotherapy. Journal of Biological Response Modifiers 1990;9:329-334.
29. Eversole LR. Histologic classification of salivary tumours. Archives of Pathology 1971;92:433-443.
30. Shirasuna K, Sato M, Miyazaki T. A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer (Philadelphia) 1981;48:745-752.
31. Hatakeyama S, Satoh M, Yoshimura N, Otsu T. Immunocytochemical localization of bone morphogenetic proteins (BMPs) in salivary gland pleomorphic adenoma. Journal of Oral Pathology and Medicine 1994;23:232-236.
32. Lianjia Y, Yan J, Hitoshi N, Shinichiro S, Akihide K, Masahiko M. An immunohistochemical study of bone morphogenetic protein in pleomorphic adenoma of the salivary gland. Virchows Archiv A 1993;422:439-443.
33. Barry MA, Behnte CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology 1990;40:23532362.
34. Thomas GC, Jacqueline MG, Fernando E, Douglas RG. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Research 1992; 12:773-780.
35. Wong GHW, Goeddel DV. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. Journal of Immunology 1994;152:1751-1755.
36. + T cell-mediated cytotoxicity. Journal of Immunology 1994; 152:1127-1133.
37. 2 induces apoptosis of murine T cell clones without downregulating bcl-2 mRNA expression. European Journal of Immunology 1994;24:1293-1300.
38. 1) enhances apoptosis in human papilloma-virus type 16immortalized human ectocervical epithelial cells. Experimental Cell Research 1995;216:65-72.